EHA 2022 | The outcomes of patients with primary refractory and relapsed acute leukemia

Name: The outcomes of patients with primary refractory and relapsed acute leukemia
Uploaded: 2022-06-12T00:00:00Z
Duration: 1 min 19 s
Description: Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, comments on the outcomes of patients with primary refractory and relapsed acute leukemia. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Arnon Nagler • 12 Jun 2022

EHA 2022

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, comments on the outcomes of patients with primary refractory and relapsed acute leukemia. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.